Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
BCAX on Nasdaq
Shares outstanding
55,000,000
Price per share
$16.91
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
57,086,225
Total reported value
$960,644,534
% of total 13F portfolios
0%
Share change
+6,905,330
Value change
+$119,761,983
Number of holders
139
Price from insider filings
$16.91
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Invus Global Management, LLC 9.6% $50,656,769 5,216,969 Raymond Debbane 30 Jun 2025
Vestal Point Capital, LP 6.5% -30% $62,669,750 -$24,980,250 3,575,000 -28% Vestal Point Capital, LP 31 Dec 2025
FMR LLC 6.1% +20% $56,333,763 +$9,946,631 3,347,223 +21% FMR LLC 31 Dec 2025
T. Rowe Price Investment Management, Inc. 5.9% $56,737,510 3,236,595 T. Rowe Price Investment Management, Inc. 31 Dec 2025
Deep Track Capital, LP 5% $48,207,500 2,750,000 Deep Track Capital, LP 05 Feb 2026

As of 31 Dec 2025, 139 institutional investors reported holding 57,086,225 shares of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX). This represents 104% of the company’s total 55,000,000 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) together control 93% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RA CAPITAL MANAGEMENT, L.P. 13% 6,955,993 0% 1.2% $117,069,362
Siren, L.L.C. 9.5% 5,216,969 0% 2.6% $87,801,588
Vestal Point Capital, LP 6.5% 3,575,000 -30% 2.2% $60,167,250
FMR LLC 6.1% 3,347,223 +24% 0% $56,333,763
T. Rowe Price Investment Management, Inc. 5.9% 3,236,595 +596% 0.03% $54,472,000
RED TREE MANAGEMENT, LLC 5.8% 3,170,509 0% 49% $53,359,666
TPG GP A, LLC 5.5% 3,010,425 0% 1.9% $50,665,453
JANUS HENDERSON GROUP PLC 4.8% 2,646,285 0.02% $44,484,051
Deep Track Capital, LP 4.8% 2,614,004 +7.7% 1% $43,993,687
BlackRock, Inc. 4.6% 2,528,451 +9.4% 0% $42,553,826
Omega Fund Management, LLC 4% 2,204,650 0% 13% $37,104,260
VANGUARD GROUP INC 4% 2,186,150 -0.67% 0% $36,792,904
STATE STREET CORP 3% 1,649,537 +179% 0% $27,761,708
FRANKLIN RESOURCES INC 2.9% 1,620,025 0.01% $27,265,020
PRICE T ROWE ASSOCIATES INC /MD/ 2.8% 1,559,535 -11% 0% $26,248,000
GEODE CAPITAL MANAGEMENT, LLC 1.5% 811,400 -2.4% 0% $13,658,764
CITADEL ADVISORS LLC 1.4% 772,258 0.01% $12,997,102
FIL Ltd 1.4% 758,493 -5.6% 0.01% $12,765,437
ACORN CAPITAL ADVISORS, LLC 1.2% 643,382 0% 3.7% $10,828,113
Aisling Capital Management LP 1% 568,919 0% 2% $9,574,907
GOLDMAN SACHS GROUP INC 1% 552,331 +137% 0% $9,295,731
MILLENNIUM MANAGEMENT LLC 0.79% 434,699 -57% 0.01% $7,315,984
Rock Springs Capital Management LP 0.78% 429,095 +16% 0.37% $7,221,669
Ensign Peak Advisors, Inc 0.73% 401,444 0.01% $6,756,303
NAN FUNG TRINITY (HK) LTD 0.68% 372,385 -3.2% 0.5% $6,267,240

Institutional Holders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 57,086,225 $960,644,534 +$119,761,983 $16.83 139
2025 Q3 49,994,786 $789,088,187 +$2,780,392 $15.79 112
2025 Q2 51,165,684 $475,330,436 -$6,689,372 $9.29 105
2025 Q1 48,567,553 $633,357,650 +$9,523,679 $13.03 92
2024 Q4 46,709,070 $813,618,424 +$73,899,338 $17.42 84
2024 Q3 36,408,664 $927,393,381 +$849,110,088 $25.47 69